Internal Medicine, Nephrology · San Francisco, CA
NPI
1912198110
Since 2007
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
929 Clay St, Ste 302
San Francisco, CA, 94108
Phone (514) 361-5086
Groups this clinician bills Medicare through
Medicare paid, 2024
$279K
3,004 services
Medicare patients, 2024
342
Average age 77
Drug cost, 2024
$2.0M
10,830 prescriptions
Company payments, 2025
$1,319
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Maian Ye was code 99214 (office e&m - established), 1,061 times for 311 patients. In total Maian Ye billed 3,004 services in 27 codes, and Medicare paid $279K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-10-14.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,061 | 311 | $115.55 | $123K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 990 | 307 | $14.42 | $14K |
| 90960 ESRD Related Services (not dialysis) | Office | 239 | 24 | $317.53 | $76K |
| 99213 Office E&M - Established | Office | 200 | 103 | $85.87 | $17K |
| 99204 Office E&M - New | Office | 76 | 76 | $147.78 | $11K |
| 96372 Injection Administration | Office | 74 | 14 | $13.97 | $1,034 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 64 | 64 | $155.77 | $9,969 |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 62 | 62 | $24.09 | $1,494 |
| 99497 Care Management/Coordination | Office | 54 | 54 | $70.48 | $3,806 |
| G0008 Administration of influenza virus vaccine | Office | 36 | 36 | $38.68 | $1,392 |
| 99215 Office E&M - Established | Office | 32 | 26 | $165.07 | $5,282 |
| G0438 Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 23 | 23 | $196.45 | $4,518 |
| 90673 Vaccine Product | Office | 23 | 23 | $81.82 | $1,882 |
| 99205 Office E&M - New | Office | 13 | 13 | $206.27 | $2,682 |
| 90658 Vaccine Product | Office | 13 | 13 | $21.42 | $278 |
By year: 2022 $291K for 2,673 services; 2023 $271K for 2,190 services; 2024 $279K for 3,004 services.
Medicare prescription drug claims, 2024
In 2024, the drug Maian Ye prescribed most often to Medicare patients was Atorvastatin Calcium, with 1,021 prescriptions and refills. In total Maian Ye wrote 10,830 Medicare prescriptions that cost $2.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 1,021 | 3,035 | 345 | $6,177 |
| Tamsulosin Hcl Generic | 589 | 1,747 | 220 | $6,014 |
| Febuxostat Generic | 444 | 1,262 | 155 | $40K |
| Amlodipine Besylate Generic | 443 | 1,323 | 157 | $2,151 |
| Losartan Potassium Generic | 436 | 1,285 | 155 | $2,904 |
| Metoprolol Succinate Generic | 336 | 1,003 | 130 | $3,240 |
| Metformin Hcl Generic | 322 | 954 | 109 | $1,993 |
| Farxiga Dapagliflozin Propanediol | 284 | 732 | 94 | $381K |
| Jardiance Empagliflozin | 271 | 617 | 80 | $338K |
| Prosol Parenteral Amino Acid 20% No.1 | 238 | 238 | Under 11 | $28K |
| Losartan-Hydrochlorothiazide Losartan/Hydrochlorothiazide | 218 | 654 | 82 | $2,501 |
| Simvastatin Generic | 182 | 544 | 71 | $1,196 |
| Pantoprazole Sodium Generic | 175 | 489 | 84 | $1,697 |
| Finasteride Generic | 162 | 484 | 66 | $1,646 |
| Triamcinolone Acetonide Generic | 162 | 173 | 92 | $1,794 |
Brand drugs: 2,085 claims; generic drugs: 8,702 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Maian Ye $1,319 ($1,319 in general payments such as food, travel and fees) from 9 companies. The largest payer was GlaxoSmithKline, LLC. with $290.
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. GSK | 4 | $290 |
| Novo Nordisk Inc NVO | 4 | $261 |
| Abbvie Inc. ABBV | 1 | $150 |
| Amgen Inc. AMGN | 8 | $137 |
| Travere Therapeutics, Inc. TVTX | 2 | $130 |
| Viatris Specialty LLC | 1 | $122 |
| AstraZeneca Pharmaceuticals LP AZN | 1 | $104 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 1 | $101 |
| Mallinckrodt Hospital Products Inc. | 1 | $23.67 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.